WASHINGTON (AP) — The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer’s anti-smoking ...

Several consumer groups have petitioned the FDA to increase the warnings about the controversial Chantix smoking-cessation drug, which has been linked to risks of suicidal behavior and hostility, ...

Scientists say the stop-smoking drug should not be a first-line treatment. Nov. 3, 2011— -- Scientists say the U.S. Food and Drug Administration (FDA) should take warnings about the stop-smoking ...

When approved by the Food and Drug Administration in 2006, the prescription drug Chantix was heralded as almost a silver bullet in the fight to help people stop smoking. Its ingredient, varenicline, ...

Kicking the habit can be hard enough, but smokers with depression face a steeper challenge. Now there’s evidence that the drug varenincline (Chantix) can help. About half of smokers who try to quit ...

Pfizer is halting global distribution of its drug Chantix after finding some pills contain elevated levels of nitrosamines, a likely carcinogen, Bloomberg reported June 24. Chantix is used to help ...

Pfizer is recalling batches of the anti-smoking drug Chantix because of a high level of a substance that could increase a user’s risk of developing cancer. The Food and Drug Administration (FDA) says ...

ABC News/Washington Times Investigation: Vet drug tests, violent side-effects. June 17, 2008 — -- Mentally distressed veterans from Iraq and Afghanistan are being recruited for government tests ...

A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

Chantix is a prescription drug that can help people quit smoking tobacco. Medicare’s prescription drug plans include coverage for certain smoking cessation drugs, including Chantix. People 65 years ...